Nisa Investment Advisors’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51.5K | Hold |
4,557
| – | – | ﹤0.01% | 1582 |
|
|
2025
Q1 | $52.6K | Buy |
4,557
+218
| +5% | +$2.52K | ﹤0.01% | 1578 |
|
|
2024
Q4 | $36.8K | Sell |
4,339
-26
| -0.6% | -$220 | ﹤0.01% | 1767 |
|
|
2024
Q3 | $50.5K | Sell |
4,365
-15
| -0.3% | -$174 | ﹤0.01% | 1643 |
|
|
2024
Q2 | $51.6K | Buy |
4,380
+29
| +0.7% | +$342 | ﹤0.01% | 1658 |
|
|
2024
Q1 | $51.6K | Buy |
4,351
+12
| +0.3% | +$142 | ﹤0.01% | 1648 |
|
|
2023
Q4 | $53.2K | Hold |
4,339
| – | – | ﹤0.01% | 1622 |
|
|
2023
Q3 | $41.8K | Hold |
4,339
| – | – | ﹤0.01% | 1777 |
|
|
2023
Q2 | $39.1K | Buy |
4,339
+1,240
| +40% | +$11.2K | ﹤0.01% | 1834 |
|
|
2023
Q1 | $24K | Hold |
3,099
| – | – | ﹤0.01% | 1955 |
|
|
2022
Q4 | $21K | Buy |
+3,099
| New | +$21K | ﹤0.01% | 2046 |
|
|
2021
Q3 | – | Sell |
-2,400
| Closed | -$58 | – | 2315 |
|
|
2021
Q2 | $58 | Buy |
+2,400
| New | +$58 | ﹤0.01% | 1894 |
|